HUP0303241A2 - Pirazolil-pirimidin-származékok, előállításuk, alkalmazásuk és az előállításukhoz használt köztitermékek - Google Patents
Pirazolil-pirimidin-származékok, előállításuk, alkalmazásuk és az előállításukhoz használt köztitermékekInfo
- Publication number
- HUP0303241A2 HUP0303241A2 HU0303241A HUP0303241A HUP0303241A2 HU P0303241 A2 HUP0303241 A2 HU P0303241A2 HU 0303241 A HU0303241 A HU 0303241A HU P0303241 A HUP0303241 A HU P0303241A HU P0303241 A2 HUP0303241 A2 HU P0303241A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- heterocyclyl
- arylalkyl
- aryl
- integer
- Prior art date
Links
- BWIHJLOBZMKPKS-UHFFFAOYSA-N 2-(1h-pyrazol-5-yl)pyrimidine Chemical class N1C=CC(C=2N=CC=CN=2)=N1 BWIHJLOBZMKPKS-UHFFFAOYSA-N 0.000 title abstract 2
- 239000000543 intermediate Substances 0.000 title 1
- -1 cyano, hydroxyl Chemical group 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000001188 haloalkyl group Chemical group 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000002843 carboxylic acid group Chemical group 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000003831 tetrazolyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10108480A DE10108480A1 (de) | 2001-02-22 | 2001-02-22 | Pyrazolylpyrimidine |
| PCT/EP2002/001400 WO2002068413A1 (de) | 2001-02-22 | 2002-02-11 | Pyrazolylpyrimidine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0303241A2 true HUP0303241A2 (hu) | 2004-01-28 |
Family
ID=7675081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0303241A HUP0303241A2 (hu) | 2001-02-22 | 2002-02-11 | Pirazolil-pirimidin-származékok, előállításuk, alkalmazásuk és az előállításukhoz használt köztitermékek |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7087616B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1363905A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2004524315A (cg-RX-API-DMAC7.html) |
| KR (1) | KR100854583B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1301992C (cg-RX-API-DMAC7.html) |
| BR (1) | BR0207509A (cg-RX-API-DMAC7.html) |
| DE (1) | DE10108480A1 (cg-RX-API-DMAC7.html) |
| HU (1) | HUP0303241A2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL157298A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA03007433A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI236475B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2002068413A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200306468B (cg-RX-API-DMAC7.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI372050B (en) * | 2003-07-03 | 2012-09-11 | Astex Therapeutics Ltd | (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles |
| MX2007008008A (es) * | 2004-12-30 | 2007-11-12 | Astex Therapeutics Ltd | Compuestos de pirazol que modulan la actividad de las cinasas cdk, gsk y aurora. |
| DE102005058418A1 (de) * | 2005-12-07 | 2007-06-21 | Bayer Cropscience Gmbh | Verfahren zur Herstellung von Haloalkyl(thio)vinimidiniumsalzen und 4-(Haloalkyl(thio))-pyrazolen und deren Umsetzung zu Pflanzenschutzmitteln |
| US8399442B2 (en) * | 2005-12-30 | 2013-03-19 | Astex Therapeutics Limited | Pharmaceutical compounds |
| JP5523829B2 (ja) * | 2006-06-29 | 2014-06-18 | アステックス、セラピューティックス、リミテッド | 複合薬剤 |
| EP2043635A2 (en) * | 2006-06-29 | 2009-04-08 | Astex Therapeutics Limited | Pharmaceutical combinations |
| DE102007003036A1 (de) * | 2006-12-20 | 2008-06-26 | Bayer Cropscience Ag | Pyrimidinylpyrazole |
| DE102007044032A1 (de) | 2007-09-14 | 2009-03-19 | Bayer Healthcare Ag | Substituierte heterocyclische Verbindungen und ihre Verwendung |
| DE102007048447A1 (de) | 2007-10-10 | 2009-04-16 | Bayer Healthcare Ag | Substituierte Dihydropyrazolthione und ihre Verwendung |
| EP2135865A1 (de) * | 2008-06-17 | 2009-12-23 | Bayer CropScience AG | Substituierte 1-(Diazinyl) pyrazol-4-yl-essigsäuren, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren |
| AU2009281457A1 (en) * | 2008-08-14 | 2010-02-18 | Bayer Cropscience Ag | Insecticidal 4-phenyl-1H-pyrazoles |
| CN102414197B (zh) | 2009-04-27 | 2015-11-25 | 美国陶氏益农公司 | 杀虫剂吡啶化合物 |
| BR112012006956A2 (pt) * | 2009-10-12 | 2015-09-15 | Bayer Cropscience Ag | 1- (pirida-3-il) -pirazóisol e 1- (pirimida-5-il) - pirazóisol como pesticidas |
| EP2499130A1 (de) | 2009-11-11 | 2012-09-19 | Bayer CropScience AG | Neue diazinyl-pyrazolylverbindungen |
| JP2012116796A (ja) * | 2010-12-01 | 2012-06-21 | Sumitomo Chemical Co Ltd | ヘテロ芳香環化合物およびその有害生物防除用途 |
| WO2013138617A1 (en) | 2012-03-16 | 2013-09-19 | Axikin Pharmaceuticals, Inc. | 3,5-diaminopyrazole kinase inhibitors |
| NZ631142A (en) | 2013-09-18 | 2016-03-31 | Axikin Pharmaceuticals Inc | Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors |
| CR20170077A (es) | 2014-08-04 | 2017-06-26 | Nuevolution As | Derivados de heterociclilo opcionalmente condensados de pirimidina útiles para el tratamiento de enfermedades inflamatorias, metabólicas, oncológicas y autoinmunitarias |
| US10118890B2 (en) | 2014-10-10 | 2018-11-06 | The Research Foundation For The State University Of New York | Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration |
| TWI703133B (zh) | 2014-12-23 | 2020-09-01 | 美商艾克斯基製藥公司 | ３,５-二胺基吡唑激酶抑制劑 |
| UY38994A (es) | 2019-12-20 | 2021-07-30 | Nuevolution As | Compuestos activos frente a receptores nucleares |
| MX2022007265A (es) | 2019-12-20 | 2022-09-09 | Nuevolution As | Compuestos activos frente a receptores nucleares. |
| WO2021198956A1 (en) | 2020-03-31 | 2021-10-07 | Nuevolution A/S | Compounds active towards nuclear receptors |
| AU2021245397A1 (en) | 2020-03-31 | 2022-10-20 | Nuevolution A/S | Compounds active towards nuclear receptors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3910910A (en) * | 1972-03-31 | 1975-10-07 | American Home Prod | (2-Pyrimidinylthio) alkanoic acids, esters, amides and hydrazides |
| US4663327A (en) * | 1984-05-23 | 1987-05-05 | Bayer Aktiengesellschaft | 1-heteroaryl-4-aryl-pyrazolin-5-ones |
| WO1994029268A1 (de) | 1993-06-07 | 1994-12-22 | Bayer Aktiengesellschaft | Iodpropargylcarbamate und ihre verwendung als biozide im pflanzen- und materialschutz |
| CN1153779A (zh) * | 1995-09-28 | 1997-07-09 | 山道士有限公司 | 2-(4-吡唑基氧基-嘧啶-5-基)乙酸衍生物 |
| EP0967212A4 (en) * | 1996-12-16 | 2002-01-09 | Sumitomo Chemical Co | PYRAZOLINE COMPOUNDS AND THEIR USE AS A MEANS FOR CONTROLLING PLANT DISEASES |
-
2001
- 2001-02-22 DE DE10108480A patent/DE10108480A1/de not_active Withdrawn
-
2002
- 2002-02-11 KR KR1020037010576A patent/KR100854583B1/ko not_active Expired - Fee Related
- 2002-02-11 HU HU0303241A patent/HUP0303241A2/hu unknown
- 2002-02-11 US US10/468,371 patent/US7087616B2/en not_active Expired - Fee Related
- 2002-02-11 JP JP2002567926A patent/JP2004524315A/ja active Pending
- 2002-02-11 CN CNB028054326A patent/CN1301992C/zh not_active Expired - Fee Related
- 2002-02-11 WO PCT/EP2002/001400 patent/WO2002068413A1/de not_active Ceased
- 2002-02-11 IL IL15729802A patent/IL157298A0/xx unknown
- 2002-02-11 EP EP02711857A patent/EP1363905A1/de not_active Withdrawn
- 2002-02-11 MX MXPA03007433A patent/MXPA03007433A/es active IP Right Grant
- 2002-02-11 BR BR0207509-1A patent/BR0207509A/pt not_active IP Right Cessation
- 2002-02-21 TW TW091102971A patent/TWI236475B/zh not_active IP Right Cessation
-
2003
- 2003-08-20 ZA ZA200306468A patent/ZA200306468B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004524315A (ja) | 2004-08-12 |
| WO2002068413A1 (de) | 2002-09-06 |
| KR20030075188A (ko) | 2003-09-22 |
| DE10108480A1 (de) | 2002-09-05 |
| CN1492864A (zh) | 2004-04-28 |
| IL157298A0 (en) | 2004-02-19 |
| BR0207509A (pt) | 2004-03-09 |
| CN1301992C (zh) | 2007-02-28 |
| TWI236475B (en) | 2005-07-21 |
| US20040102465A1 (en) | 2004-05-27 |
| KR100854583B1 (ko) | 2008-08-27 |
| EP1363905A1 (de) | 2003-11-26 |
| US7087616B2 (en) | 2006-08-08 |
| ZA200306468B (en) | 2005-02-04 |
| MXPA03007433A (es) | 2003-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0303241A2 (hu) | Pirazolil-pirimidin-származékok, előállításuk, alkalmazásuk és az előállításukhoz használt köztitermékek | |
| NO20051411L (no) | Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk bruk derav samt intermediater til fremstilling derav | |
| NL300877I2 (nl) | obeticholzuur | |
| MY136959A (en) | Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof | |
| DE602004024880D1 (de) | Azetidincarboxamid-derivate zur verwendung zur behandlung von cb1-rezeptor-vermittelten krankheiten | |
| TW200635585A (en) | Monocyclic substituted methanones | |
| TW200732329A (en) | Aryl-isoxazolo-4-yl-oxadiazole derivatives | |
| NO20023823D0 (no) | Fremgangsmåte for tilvirkning og bruk av pyrrolopyrimidinon- derivater | |
| HUP0300920A1 (hu) | Szubsztituált benzidszármazékok és gyógyszerként történő felhasználásuk | |
| SE0200411D0 (sv) | Novel use | |
| BR0208805A (pt) | Uso de um derivado de pirazolina | |
| MX2009012380A (es) | Compuestos de heteroarilamida pirimidona. | |
| ATE396182T1 (de) | Hemmstoffe des ep4-rezeptors | |
| KR101514593B1 (ko) | 5-(메틸-1ｈ-이미다졸-1-일)-3-(트리플루오로메틸)-벤젠아민의 합성 방법 | |
| EA200971063A1 (ru) | Ариламидпиримидоновые соединения | |
| HUP0001957A2 (hu) | Gombaellenes hatású, piridingyűrűben karbonsavszármazékokkal helyettesített 2-(metoxi-imino)-2-(piridinil-oxi-metil)-fenil-acetamid-származékok, intermedierjeik, előállításuk és alkalmazásuk | |
| DE60336735D1 (de) | Neue biologischaktive molekü le | |
| DK1694641T3 (da) | Prostaglandinsyntese | |
| DE60109829D1 (de) | 3-(1-Hydroxy-pentylidene)-5-nitro-3H-benzofuran-2-on, ein Verfahren zu seiner Herstellung und seine Verwendung | |
| TW200619201A (en) | Process for the preparation of pyrazoles | |
| NO20033049D0 (no) | Fremgangsmåte for fremstilling av (+/-) trans-4-p-fluorfenyl- 3-hydroksymetyl-1 | |
| TW200635911A (en) | Sulfanyl substituted phenyl methanones | |
| DE602005008099D1 (de) | Pyrrolopyridin-2-karbonsäureamid-derivat zur verwendung als inhibitor gegen glykogenphosphorylase | |
| ATE363460T1 (de) | Verfahren zur herstellung von fluorhalogenalkanen | |
| HUP0302121A2 (hu) | {[(Biciklil- vagy heterobiciklil-metil)-szulfonil]-alkil}-csoporttal szubsztituált N-hidroxi-formamidok, eljárás előállításukra, intermedierek és a vegyületeket tartalmazó gyógyszerkészítmények |